| 12/06/25 | GSK | 11:00:00 | 12 Jun 2025 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 25/05/22 | GSK | 15:41:00 | 25 May 2022 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 01/12/21 | GSK | 11:05:00 | 1 Dec 2021 | | GSK | Total Voting Rights | GSK plc | PRN |
| 11/08/14 | | 17:27:54 | 11 Aug 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 08/08/14 | | 17:10:50 | 8 Aug 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 08/08/14 | | 17:07:45 | 8 Aug 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 05/08/14 | | 11:37:52 | 5 Aug 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 04/08/14 | | 14:28:46 | 4 Aug 2014 | | | Publication of Prospectus | GlaxoSmithKline PLC | RNS |
| 01/08/14 | | 13:19:46 | 1 Aug 2014 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 24/07/14 | | 18:47:28 | 24 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 24/07/14 | | 09:32:44 | 24 Jul 2014 | | | Blocklisting Interim Review | GlaxoSmithKline PLC | RNS |
| 23/07/14 | | 13:00:04 | 23 Jul 2014 | | | Half Yearly Report | GlaxoSmithKline PLC | RNS |
| 21/07/14 | | 18:47:08 | 21 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 21/07/14 | | 18:45:30 | 21 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 21/07/14 | | 18:44:23 | 21 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 21/07/14 | | 18:38:36 | 21 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 18/07/14 | | 17:27:42 | 18 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 18/07/14 | | 17:25:42 | 18 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 18/07/14 | | 17:24:16 | 18 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 17/07/14 | | 15:00:02 | 17 Jul 2014 | | | MEK/BRAF combination phase III study update | GlaxoSmithKline PLC | RNS |
| 16/07/14 | | 17:59:03 | 16 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/07/14 | | 08:00:26 | 16 Jul 2014 | | | Start of phase III study - FF/UMEC/VI combination | GlaxoSmithKline PLC | RNS |
| 14/07/14 | | 17:11:58 | 14 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 14/07/14 | | 17:11:51 | 14 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/07/14 | | 18:07:09 | 11 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/07/14 | | 18:05:44 | 11 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/07/14 | | 18:03:55 | 11 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/07/14 | | 17:37:00 | 10 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/07/14 | | 17:23:09 | 10 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/07/14 | | 17:18:24 | 10 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 08/07/14 | | 16:57:23 | 8 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 07/07/14 | | 18:00:02 | 7 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 02/07/14 | | 16:11:26 | 2 Jul 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/07/14 | | 11:53:08 | 1 Jul 2014 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 30/06/14 | | 18:17:23 | 30 Jun 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 30/06/14 | | 14:00:04 | 30 Jun 2014 | | | Breo Ellipta US regulatory submission | GlaxoSmithKline PLC | RNS |
| 27/06/14 | | 13:42:13 | 27 Jun 2014 | | | Triumeq receives positive CHMP opinion | GlaxoSmithKline PLC | RNS |
| 24/06/14 | | 18:30:35 | 24 Jun 2014 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 23/06/14 | | 18:14:41 | 23 Jun 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 17/06/14 | | 17:55:01 | 17 Jun 2014 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 16/06/14 | | 18:20:04 | 16 Jun 2014 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 13/06/14 | | 18:46:49 | 13 Jun 2014 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 13/06/14 | | 15:03:46 | 13 Jun 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/06/14 | | 17:54:43 | 12 Jun 2014 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 11/06/14 | | 18:36:40 | 11 Jun 2014 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 11/06/14 | | 16:53:27 | 11 Jun 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/06/14 | | 16:50:28 | 11 Jun 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/06/14 | | 13:30:03 | 11 Jun 2014 | | | Incruse Ellipta positive data studies | GlaxoSmithKline PLC | RNS |
| 09/06/14 | | 19:01:39 | 9 Jun 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 09/06/14 | | 18:45:47 | 9 Jun 2014 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |